Change Healthcare reported Q2 fiscal 2021 results with total revenue of $755.9 million, a net loss of $42.6 million or $0.13 per diluted share. Adjusted net income was $103.5 million ($0.32 per share) and adjusted EBITDA reached $231.8 million. Financial performance was impacted by the COVID-19 pandemic, but new sales volumes across segments grew. The company acquired Nucleus.io and Prometheus Analytics, enhancing its technology offerings. For Q3 fiscal 2021, guidance indicates solutions revenue between $725 million and $745 million.
Change Healthcare (Nasdaq: CHNG) will announce its second quarter fiscal 2021 financial results after market close on November 4, 2020. A conference call will follow at 8:00 a.m. ET on November 5, 2020, to discuss these results. Investors can participate in the call by dialing 1-(877) 279-0788 (U.S.) or 1-(270) 215-9894 (international) with the conference ID 6559165. A replay of the call will be available, and more information can be found on the company's website.